A Randomized, Double Blind, Parallel-Group Study Of Cardiovascular Safety In Osteoarthritis or Rheumatoid Arthritis
Patients With or at High Risk for Cardiovascular disease Comparing Celecoxib With Naproxen and Ibuprofen.
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Glucose Lowering
Effects and Safety of a Novel Study Drug When Added to Glimepiride in Subjects with Type 2 Diabetes Mellitus
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of the Efficacy and Safety of a Novel
Study Drug as Monotherapy for Type 2 Diabetes Mellitus
Pulmonary Outcomes within a 2-Year Period in Subjects with Diabetes Mellitus Treated with Technosphere®/Insulin
or Usual Antidiabetic Treatment and in Subjects without Abnormalities in Glucose Control.
(C LF0242780-01 05 01) III phase
A multicenter, double-blind, randomized, active comparator, forced-titration study to compare the efficacy and
safety of the combination of 145 mg fenofibrate and 20 or 40 mg simvastatin with 40 mg simvastatin monotherapy
in patient with mixed dyslipidemia at risk of
cardiovascular disease not adequately controlled by 20 mg simvastatin alone.
Double-Blind, Triple Dummy, Parallel-Group, Randomized, Six-Month Study to Compare Celecoxib (200 mg BID) with
Diclofenac SR (75 mg BID) plus Omeprazole (20 mg QD) for Gastrointestinal Events in Subjects with Osteoarthritis
and Reumatoid Arthritis at High-Risk of Gastrointestinal Adverse Events.
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and
Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects with Nonvalvular Atrial Fibrillation.
A 24-week, multicenter, multinational, randomized, double-blind, triple-dummy, 3-arm parallel group study
comparing the efficacy and safety of CHF 1535 200/6 (beclomethasone dipropionate 200 ug plus formoterol 6
ug/actuation), 2 puffs b.i.d., versus beclomethasone diproprionate HFA (250 ug/actuation), 4 puffs b.i.d., versus
Seretide® 500/50 (fluticasone 500 ug plus salmeterol 50 ug/actuation), 1 inhalation b.i.d., in patients with severe
“A phase 3, 24-Week, Multi-Center, Open-Label, Randomized, Controlled Trial Comparing the Efficacy and Safety of
Prandial Inhalation of Technosphere®/Insulin in Combination with Metformin or Technosphere®/Insulin Alone
Versus 2 Oral Antidiabetic Agents (Metformin and a Secretagougue) in Subjects With Type 2 Diabetes Mellitus Sub-
Optimally Controlled on Combination Metformin and a Secretagogue”.
Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left
ventricular systolic dysfunction
A three-year randomised double-blind placebo-controlled international multicentre study.
Randomized, Double-Blind, Controlled Trial III phase, assessment the efficacy and safety of the Ferinject® with
comparison to the placebo in patients with Iron deficiency and chronic Heart Failure.
A phase III randomized, double-blind, parallel-group, multi-center study of the safety and efficacy of Apixaban for
prophylaxis of venous thromboembolism in acutely ill medical subjects during and following hospitalization.
A Randomized, Double-blind, Placebo-Controlled Proof of Concept Study to Evaluate the Safety and Efficacy of Oral
TAK-783 in the Treatment of the Signs and Symptoms in Subjects with Rheumatoid Arthritis.
A Phase 2 Multi-dose, Double-blind, Placebo-controlled, Randomized, Multicenter study of MDX-1100 (anti-CXCL10
Human Monoclonal Antibody) in Patients with Active Rheumatoid Arthritis (RA).
A Multicenter, Randomized, Double-Blind, Active Controlled, Parallel Group, Phase 3 Trial Evaluate the Safety and
Efficacy of Dapagliflozin in Combination with Metformin as Initial Therapy as Compared with Dapagliflozin
Monotherapy and Metformin Monotherapy in Subjects with Type 2 Diabetes Who Have Inadequate Glycemic Control.
A randomized, double-blind, parallel-group add-on study of hydrochlorothiazide in subjects with moderate to severe
hypertension not achieving target blood pressure on olmesartan medoxomil/amlodipine fixed dose combination
40/10 mg alone.
A multicenter, randomized, open label, active-comparator controlled study to assess the efficacy, safety and
tolerability of taspoglutide compared to
exenatide in patients with type 2 diabetes mellitus inadequately controlled with
metformin, thiazolidinedione or a combination of both.
FELT, (REC 15/2375-IT-CL 0336)
An international multicentre, randomized, parallel group, double-blind trial to evaluate different dose combinations
Lercanidipine and enalapril in comparison with each component administered alone and with placebo in patients
with essential hypertension
A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study to Evaluate the Safety and Efficacy of CCX354-C in
Subjects with Rheumatoid Arthritis Partially Responsive to Methotrexate Therapy.
Study Administration Information for A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter,
Dose Ranging Study to Evaluate the Efficacy and Safety of Losmapimod (GW856553) Tablets Administered Twice
Daily compared with Placebo for 24 Weeks in Adult Subjects with Chronic Obstructive Pulmonary Disease (COPD).
A Phase 2 Randomised, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Efficacy
and Safety of CAM-3001 in Subjects with Rheumatoid Arthritis.
A multicentre, international, randomised, parallel group, double blind study to evaluate Cardiovascular safety of
linagliptin versus glimepiride in patients with type 2 diabetes mellitus at high cardiovascular risk.
Effect of inhalation of tiotropium once daily 18 mcg versus salmeterol twice daily 50 mcg on time to first
exacerbation in COPD patients (a andomized, double-blind, double-dummy, parallel group, one-year study).
The Effect of Eplerenone versus Placebo on Cardiovascular Mortality and Heart Failure Hospitalization in Patients
with NYHA Class II Chronic Systolic Heart Failure.
A Randomized, Double-Blind, Placebo and Active-Controlled, 4-Arm, Parallel-Group, Multicenter Study to Evaluate
the Efficacy, Safety, and Tolerability of JNJ-28431754 (Canagliflozin) Compared with Sitagliptin and Placebo in the
Treatment of Subject with Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformine Monotherapy
A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of JNJ-28431574 on
Cardiovascular out comes in Adult Subjects With Type2 Diabetes Mellitus, The CANVAS Trial (CANagliflozin cardio
Vascular Assessmen Study).
An exercise endurance study to evaluate the effects of treatment of COPD patients with a dual bronchodilator:
A Phase IIB, Multi-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study of the Efficacy and
Safety of Fostamatinib Disodium Monotherapy Compared with Adalimumab Monotherapy in Patients with Active
A Long-term Extension Study to Assess the Safety and Efficacy of Fostamatinib Disodium (FosD) in the Treatment of
A Multi-Centre, Randomised, Double'Blind,Placebo- Controlled,ParalleFGroup Study of the Effect of
Fostamatinib100mg Twice Dailyon 24-hour Ambulatory Blood Pressurein Patients with RheumatoidArthritis
A Phase 3, Randomized, Double-blind, Placebo-controlled,Parallel group Study to Evaluate the Efficacy and Safety of
Ranolazine When Added to Metformin in Subjects with Type 2 Diabetes Mellitus
Copyright © 2014 - Zmeev S., Juravlev N., Tabachnikov V.